REFERENCIAS BIBLIOGRAFICAS

  • Chiang, John. (2014). Liver Physiology: MetaboLism and Detoxification. 10.1016/B978-0-12-386456-7.04202-7.
  • Niu L, Geyer PE, Gupta R, Santos A, Meier F, Doll S, Wewer Albrechtsen NJ, Klein S, Ortiz C, Uschner FE, Schierwagen R, Trebicka J, Mann M. Dynamic human liver proteome atlas reveals functional insights into disease pathways. Mol Syst Biol. 2022 May;18(5):e10947.
  • Gundert-Remy U, Bernauer U, Blömeke B, Döring B, Fabian E, Goebel C, Hessel S, Jäckh C, Lampen A, Oesch F, Petzinger E, Völkel W, Roos PH. Extrahepatic metabolism at the body’s internal-external interfaces. Drug Metab Rev. 2014 Aug;46(3):291-324. doi: 10.3109/03602532.2014.900565. Epub 2014 Mar 25. PMID: 24666398.
  • Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr;138(1):103-41.
  • Guengerich FP. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions. Chem Res Toxicol. 2017 Jan 17;30(1):2-12. doi: 10.1021/acs.chemrestox.6b00226. Epub 2016 Aug 11. PMID: 27472660; PMCID: PMC5293730.
  • Danielson P. B. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Current Drug Metabolism. 2002;3(6):561–597. doi: 10.2174/1389200023337054.
  • Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism xenobiotics. Cell Mol Life Sci 2001; 58(5–6):737–747.
  • Zhong J, Karlsson O, Wang G et al. B vitamins attenuate the epigenetic effects of ambient fine particles in a pilot human intervention trial. Proc Natl Acad Sci; published ahead of print March 13, 2017; doi: 10.1073/pnas.1618545114.
  • Xu SF, Hu AL, Xie L, Liu JJ, Wu Q, Liu J. Age-associated changes of cytochrome P450 and related phase-2 gene/proteins in livers of rats. PeerJ. 2019 Aug 2;7:e7429.
  • Jančová, P., Anzenbacher, P., & Anzenbacherová, E. (2010). Phase II drug metabolizing enzymes. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 154 2, 103-16.
  • Kiang TKL, Ensom MHH, Chang TKH. UDP-glucurono syl transferases and clinical drug-drug interactions. Pharmacol Ther 2005; 106(1):97–132.
  • Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002; 50(2):259– 265.
  • Guo, C.; Xie, C.; Ding, P.; Qin, G.; Mo, W.; Cao, X.; Zheng, S. Quantification of glycocholic acid in human serum by stable isotope dilution ultra performance liquid chromatography electrospray ionization tandem mass spectrometry. J. Chromatogr. B 2018, 1072, 315–319.
  • Falany, C.N.; Johnson, M.R.; Barnes, S.; Diasio, R.B. Glycine and Taurine Conjugation of Bile Acids by a Single Enzyme. Molecular cloning and expression of human liver bile acid CoA: Amino acid N-acyltransferase. J. Biol. Chem. 1994, 269, 19375–19379.
  • Giancarlo Aldini, Alessandra Altomare, Giovanna Baron, Giulio Vistoli, Marina Carini, Luisa Borsani & Francesco Sergio (2018) N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why, Free Radical Research, 52:7, 751-762.
  • Liska DJ. The detoxification enzyme systems. Alt Med Rev 1998;3(3):187-198.
  • Ueda K, Clark DP, Chen CJ,et al. (The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 1987;262(2):505-508.
  • Chin KV, Pastan I, Gottesman MM. Function and regulation of the multidrug resistance gene. Adv Cancer Res 1993;60:157-180.
  • Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129-134.15.
  • Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010 Mar;62(1):1-96.
  • Rowland IR (Ed). Role of the gut flora in toxicity and cancer. London: Academic Press, 1988.
  • Leung JW, Liu YL, Leung PS, et al. Expression of bacterial beta-glucuronidase in human bile: an in vitro study. Gastrointest Endosc 2001;54(3):346-350
  • Cheng KW, Tseng CH, Chen IJ, Huang BC, Liu HJ, Ho KW, Lin WW, Chuang CH, Huang MY, Leu YL, Roffler SR, Wang JY, Chen YL, Cheng TL. Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis. Pharmacol Res. 2022 Mar;177:106115.
  • Sears ME, Genuis SJ. Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J Environ Public Health. 2012;2012:356798.
  • Shade C. Mercury and the human detoxification system. Quicksilver Scientific, LLC Lafayette. (11-Sept-2010
  • Faghfouri AH, Zarrin R, Maleki V, Payahoo L, Khajebishak Y. A comprehensive mechanistic review insight into the effects of micronutrients on toll-like receptors functions. Pharmacol Res. 2020 Feb;152:104619.
  • Ahn H, Lee GS. Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical inflammasomes by the inhibition of caspase-1 activity. Sci Rep. 2020 Nov 5;10(1):19091.
  • Kim SM, Ha JS, Han AR, Cho SW, Yang SJ. Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation. BMB Rep. 2019 Oct;52(10):613-618.
  • Dyall SC, Balas L, Bazan NG, Brenna JT, Chiang N, da Costa Souza F, Dalli J, Durand T, Galano JM, Lein PJ, Serhan CN, Taha AY. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions. Prog Lipid Res. 2022 Apr;86:101165.
  • Fuller R, et al. Pollution and health: a progress update. Lancet Planet Health. 2022 Jun;6(6):e535-e547.
  • Gasmi A, Noor S, Menzel A, Doşa A, Pivina L, Bjørklund G. Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. Curr Med Chem. 2020 Aug 24. doi: 10.2174/0929867327666200824112056. Epub ahead of print. PMID: 32838708.
  • Hristov BD. The Role of Glutathione Metabolism in Chronic Illness Development and Its Potential Use as a Novel Therapeutic Target. Cureus. 2022 Sep 28;14(9):e29696.